Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | St John, Ashley L. | - |
dc.contributor.author | Choi, Hae Woong | - |
dc.contributor.author | Walker, Q. David | - |
dc.contributor.author | Blough, Bruce | - |
dc.contributor.author | Kuhn, Cynthia M. | - |
dc.contributor.author | Abraham, Soman N. | - |
dc.contributor.author | Staats, Herman F. | - |
dc.date.accessioned | 2021-08-31T10:51:05Z | - |
dc.date.available | 2021-08-31T10:51:05Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-02-05 | - |
dc.identifier.issn | 2059-0105 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/57697 | - |
dc.description.abstract | Cocaine is one of the most potent and addictive psychostimulants known and there are no available pharmacotherapies to treat cocaine addiction. Here we describe a novel cocaine vaccine employing the mucosal adjuvant and mast cell-activating oligopeptide, mastoparan-7 (M7), to achieve optimal IgA antibody responses in mucosal secretions and effective induction of humoral immunity using a short immunization protocol. This formulation, using a hapten-carrier system to deliver cocaine as antigen, also reduced cocaine penetration of the blood brain barrier and protected mice from its psychoactive effects by reducing cocaine-induced locomotion. Surprisingly, the magnitude of cocaine-specific antibody titers induced by each adjuvant was not the major determinant of functional protection from cocaine challenge. A side-by-side comparison of the two haptens, cocaine and its analog GNC demonstrated that cocaine haptenation resulted in superior functional protection when used in combination with the novel mucosal adjuvant, M7. These results provide a new potential strategy for combatting cocaine addiction through mucosal vaccination. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | IMMUNIZATION | - |
dc.subject | IMMUNITY | - |
dc.subject | IMMUNOGENICITY | - |
dc.subject | PROTECTS | - |
dc.title | Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Hae Woong | - |
dc.identifier.doi | 10.1038/s41541-020-0161-1 | - |
dc.identifier.scopusid | 2-s2.0-85079069914 | - |
dc.identifier.wosid | 000511220400001 | - |
dc.identifier.bibliographicCitation | NPJ VACCINES, v.5, no.1 | - |
dc.relation.isPartOf | NPJ VACCINES | - |
dc.citation.title | NPJ VACCINES | - |
dc.citation.volume | 5 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | IMMUNIZATION | - |
dc.subject.keywordPlus | IMMUNITY | - |
dc.subject.keywordPlus | IMMUNOGENICITY | - |
dc.subject.keywordPlus | PROTECTS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.